We are live on ! Find out more
LI

Louisbourg Investments Portfolio holdings

AUM $542M
1-Year Est. Return 21.44%
This Fund
S&P 500
This Quarter Est. Return
+4.07%
1 Year Est. Return
+21.44%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$502M
AUM Growth
+$43.7M
Cap. Flow
+$27.1M
Cap. Flow %
5.4%
Top 10 Hldgs %
25.33%
Holding
225
New
17
Increased
63
Reduced
60
Closed
12

Top Buys

Rank Stock Value
1
BGSI
Boyd Group Services
BGSI
+$7.44M
2
CSGP icon
CoStar Group
CSGP
+$5.29M
3
UUUU icon
Energy Fuels
UUUU
+$5.16M
4
HBM icon
Hudbay
HBM
+$4.46M
5
EQX icon
Equinox Gold
EQX
+$4.36M

Sector Composition

Rank Sector Weight
1 Technology 19.17%
2 Materials 14.24%
3 Industrials 12.94%
4 Financials 10.07%
5 Communication Services 8.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CCJ icon
176
Cameco
CCJ
$43B
$9.17K ﹤0.01%
+100
New +$9.01K
OGI
177
Organigram Holdings
OGI
$173M
$8.43K ﹤0.01%
5,000
ACHR icon
178
Archer Aviation
ACHR
$5.18B
$5.6K ﹤0.01%
745
+480
+181% +$4.52K
RIOT icon
179
Riot Platforms
RIOT
$7.65B
$5.45K ﹤0.01%
430
COIN icon
180
Coinbase
COIN
$39.2B
$5.2K ﹤0.01%
+23
New +$6.85K
SNDL icon
181
Sundial Growers
SNDL
$323M
$4.81K ﹤0.01%
2,900
CRSP icon
182
CRISPR Therapeutics
CRSP
$5.23B
$4.2K ﹤0.01%
80
+20
+33% +$1.2K
OTEX icon
183
Open Text
OTEX
$5.81B
$3.59K ﹤0.01%
110
CRCL
184
Circle Internet Group
CRCL
$18.1B
$3.57K ﹤0.01%
45
+12
+36% +$1.24K
INTC icon
185
Intel
INTC
$493B
$3.56K ﹤0.01%
110
+50
+83% +$1.89K
PACB icon
186
Pacific Biosciences
PACB
$354M
$3.55K ﹤0.01%
+1,900
New +$3.65K
TWST icon
187
Twist Bioscience
TWST
$7.72B
$3.01K ﹤0.01%
+95
New +$2.96K
VRTX icon
188
Vertex Pharmaceuticals
VRTX
$134B
$2.72K ﹤0.01%
6
AMAT icon
189
Applied Materials
AMAT
$417B
$2.57K ﹤0.01%
10
BNT
190
Brookfield Wealth Solutions
BNT
$12.4B
$2.44K ﹤0.01%
53
-1
-2% -$46
GSSC icon
191
GS ActiveBeta US Small Cap Equity ETF
GSSC
$1.1B
$2.27K ﹤0.01%
30
NVTS icon
192
Navitas Semiconductor
NVTS
$3.55B
$2.14K ﹤0.01%
+300
New +$2.89K
CRL icon
193
Charles River Laboratories
CRL
$13.5B
$2K ﹤0.01%
10
RXRX icon
194
Recursion Pharmaceuticals
RXRX
$1.8B
$1.94K ﹤0.01%
+475
New +$2.35K
MRNA icon
195
Moderna
MRNA
$24.2B
$1.83K ﹤0.01%
62
NTLA icon
196
Intellia Therapeutics
NTLA
$1.68B
$1.8K ﹤0.01%
+200
New +$2.75K
TEM
197
Tempus AI
TEM
$10B
$1.77K ﹤0.01%
+30
New +$2.35K
XRAY icon
198
Dentsply Sirona
XRAY
$2.31B
$1.14K ﹤0.01%
100
GLXY
199
Galaxy Digital Inc
GLXY
$3.92B
$1.12K ﹤0.01%
50
MARA icon
200
Marathon Digital Holdings
MARA
$3.74B
$1.03K ﹤0.01%
115

Similar funds

Louisbourg Investments's Q4 2025 Portfolio in Review

As of Q4 2025, Louisbourg Investments held 225 positions worth $502M, up 9.5% from $458M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Louisbourg Investments deployed $27.1M of net new capital in Q4 2025, opening 17 new positions and adding to 63 existing holdings. Its largest new stake was Boyd Group Services: 46,456 shares worth $7.27M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Materials and Industrials.

On the sell side, the largest reduction was Shopify, an estimated $5.55M trimmed.

  • Louisbourg Investments's largest Q4 2025 buy was Boyd Group Services: 46,456 shares worth $7.27M.
  • Louisbourg Investments added most to CoStar Group in Q4 2025, an estimated $5.29M increase.
  • Louisbourg Investments's biggest Q4 2025 reduction was Shopify, cutting an estimated $5.55M.
  • Louisbourg Investments fully exited Sandstorm Gold in Q4 2025, selling an estimated $4.23M.
  • Louisbourg Investments's ten largest holdings make up 25% of its $502M portfolio in Q4 2025.
  • Louisbourg Investments opened 17 new positions and closed 12 in Q4 2025.
  • Louisbourg Investments's portfolio value rose 9.5% quarter-over-quarter to $502M.

Based on Louisbourg Investments's 13F filing for Q4 2025, filed 16 Jan 2026.